Government to pharma companies: stop registering sham patents to delay generics

Mike Masnick writes that the Federal Trade Commission has taken a dim view of sham patents registered by pharmaceutical companies to spook competitors eager to release generic drugs.

…despite enforcement against such abuse years ago, it seems that the FTC and the FDA have kinda let these things slip over the past few years. — Read the rest